Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
2000-07-13
2004-02-03
Look, Edward K. (Department: 3754)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
C604S919000
Reexamination Certificate
active
06685672
ABSTRACT:
BACKGROUND OF THE INVENTION
This invention relates generally to a catheter device and methods for the site-specific delivery of agents to biological spaces in medical procedures. More particularly, the invention relates to a catheter device utilizing multiple balloons and a method of site-specific delivery of agents into blood vessels for treatment of the heart.
Heart disease (atherosclerotic cardiovascular disease) is the leading cause of death in the United States. One form of heart disease is caused by the formation of sclerotic plaques within blood vessels. These plaques prevent blood from flowing freely though vessels to the tissues the vessels supply. The most dangerous plaques are those which form in the coronary arteries, preventing the flow of oxygenated blood through the coronary arteries to the heart.
There are generally two surgical procedures for treating heart disease. One procedure involves methods to increase blood supply to the effected areas of the heart by clearing sclerotic plaques from the existing vessels. In angioplasty, for example, a small dilating balloon is inserted into the vessel to open the vessel to increase blood flow. A second procedure involves providing new pathways for blood flow. New pathways can be created by grafting in vessels (coronary artery bypass surgery) or inducing the growth and development of new collateral vessels (therapeutic angiogenesis).
The induction of new collateral vessels can be achieved by injections of angiogenic agents directly into the heart tissue, vessels (coronary arteries), or the space surrounding the heart (pericardium). Direct injections of agents into the heart muscle or vessels can result in tissue injury, scarring and rapid washout of the agent away from the target site. Furthermore, these direct injections require a surgical procedures which are more costly and require a longer recovery period than catheter based procedures.
Catheters have been designed using occlusion balloons to create a pocket for drug delivery within a vessel. See, for example, U.S. Pat. No. 4,824,436 to Wolinsky, which has been incorporated by reference as if set forth herein. The balloons of the Wolinksy catheter prevent agents from escaping distally or proximally from the target zone of the vessel. One problem that this design does not address, however, is the washout of the delivered therapeutic agent through side branch vessels which may be within the target vessel segment.
Particularly with injections into the coronary artery, side branches coming off of the coronary artery can siphon agents away very quickly, thus reducing the concentration of the agent and the duration during which the agent is in contact with the target tissue. The reduced concentration and the reduced time of exposure make it less likely that the agent will have the desired effect on the target tissue. One way to address the washout through side branches is to use a catheter which occludes the side branches.
Introducing an agent to the target vessel while the side branches are occluded allows the agent to be contained in a precise segment of the target vessel. This is beneficial in that: 1) a lower dose of drug can be used due to the low blood volume of the occluded vessel segment, 2) the low rate of escape via side branches allows a higher concentration of the agent to be maintained at the target site over a longer period, and 3) the agents are kept out of systemic circulation where the agent may cause adverse side effects.
However, the side branch vessels are small and thus difficult to access. A further concern is that in placing an occlusion balloon directly into a branch vessel it creates the risk that the vessel could be punctured (and damaged), which could lead to bleeding. Thus, a catheter device and method of delivering agents site-specifically to the target vessel which minimizes these risks is needed.
BRIEF SUMMARY OF THE INVENTION
The present invention provides an improved agent delivery catheter which obviates for practical purposes, the above mentioned limitations.
One feature of the invention is a device for delivering an agent to a precise segment of a target vessel while minimizing diffusion of the agent into side branch vessels during catheterization of a defined target vessel.
Another feature of the invention is a catheter device which allows for precise control of the agent delivery pocket at a defined target vessel, such as the coronary arteries.
In accordance with one aspect of the present invention, the catheter includes at least three inflatable balloons located at fixed positions along a shaft, wherein each balloon has independent inflation control.
In accordance with another aspect of the present invention, the catheter includes at least two inflatable balloons, wherein each balloon has independent inflation control. Further, the catheter may include a fixed distal balloon and a sliding proximal balloon.
The catheters may include at least one lumen which communicates with the agent delivery pocket for the site specific introduction of agents into or collection of agents from the target vessel segment.
The catheter may include at least one lumen, wherein the lumen contains a guidewire.
The catheter may include marker bands on the shaft, such that the marker bands can be used to detect the position of the balloons relative to one another and/or relative to the branch vessels.
REFERENCES:
patent: 4423725 (1984-01-01), Baran et al.
patent: 4531936 (1985-07-01), Gordon
patent: 4637396 (1987-01-01), Cook
patent: 4655746 (1987-04-01), Daniels et al.
patent: 4824436 (1989-04-01), Wolinsky
patent: 4911163 (1990-03-01), Fina
patent: 4968306 (1990-11-01), Huss et al.
patent: 5071428 (1991-12-01), Chin et al.
patent: 5087244 (1992-02-01), Wolinsky et al.
patent: 5112305 (1992-05-01), Barath et al.
patent: 5167628 (1992-12-01), Boyles
patent: 5176643 (1993-01-01), Kramer et al.
patent: 5178608 (1993-01-01), Winters
patent: 5254089 (1993-10-01), Wang
patent: 5269326 (1993-12-01), Verrier
patent: 5279565 (1994-01-01), Klein et al.
patent: 5304121 (1994-04-01), Sahatjian
patent: 5306250 (1994-04-01), March et al.
patent: 5368566 (1994-11-01), Crocker
patent: 5397307 (1995-03-01), Goodin
patent: 5415636 (1995-05-01), Forman
patent: 5458568 (1995-10-01), Racchini et al.
patent: 5462529 (1995-10-01), Simpson et al.
patent: 5464395 (1995-11-01), Faxon et al.
patent: 5484412 (1996-01-01), Pierpont
patent: 5514092 (1996-05-01), Forman et al.
patent: 5523092 (1996-06-01), Hanson et al.
patent: 5527292 (1996-06-01), Adams et al.
patent: 5538504 (1996-07-01), Linden et al.
patent: 5538512 (1996-07-01), Zenzon et al.
patent: 5554114 (1996-09-01), Wallace et al.
patent: 5554119 (1996-09-01), Harrison et al.
patent: 5558642 (1996-09-01), Schweich, Jr. et al.
patent: 5569184 (1996-10-01), Crocker et al.
patent: 5569215 (1996-10-01), Crocker
patent: 5571086 (1996-11-01), Kaplan et al.
patent: 5599306 (1997-02-01), Klein et al.
patent: 5609574 (1997-03-01), Kaplan et al.
patent: 5626562 (1997-05-01), Castro
patent: 5634895 (1997-06-01), Igo et al.
patent: 5652225 (1997-07-01), Isner
patent: 5662609 (1997-09-01), Slepian
patent: 5674192 (1997-10-01), Sahatjian et al.
patent: 5681278 (1997-10-01), Igo et al.
patent: 5693029 (1997-12-01), Leonhardt
patent: 5698531 (1997-12-01), Nabel et al.
patent: 5709874 (1998-01-01), Hanson et al.
patent: 5713860 (1998-02-01), Kaplan et al.
patent: 5716340 (1998-02-01), Schweich, Jr. et al.
patent: 5728068 (1998-03-01), Leone et al.
patent: 5772632 (1998-06-01), Forman
patent: 5795318 (1998-08-01), Wang et al.
patent: 5797870 (1998-08-01), March et al.
patent: 5817144 (1998-10-01), Gregory
patent: 5827216 (1998-10-01), Igo et al.
patent: 5833658 (1998-11-01), Levy et al.
patent: 5836905 (1998-11-01), Lemelson et al.
patent: 5836967 (1998-11-01), Schneider
patent: 5843051 (1998-12-01), Adams et al.
patent: 5855563 (1999-01-01), Kaplan et al.
patent: 5865794 (1999-02-01), Castro
patent: 5873865 (1999-02-01), Horzewski et al.
patent: 5876373 (1999-03-01), Giba et al.
patent: 5882334 (1999-03-01), Sepetka et al.
patent: 5925016 (1
Condino Debra D.
Edwards Lifesciences Corporation
Fristoe, Jr. John K
Look Edward K.
Stradling Yocca Carlson & Rauth
LandOfFree
Multi-balloon drug delivery catheter for angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multi-balloon drug delivery catheter for angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-balloon drug delivery catheter for angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3339725